Where is I-Nside located?

I-Nside is headquartered in Strasbourg, France.

Is I-Nside a funded company?

I-Nside is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does I-Nside rank among its competitors?

I-Nside ranks 4th amongst 4 active competitors, only 1 of which is funded. EnvantageDX, which secured $1.14M in Jan, 2021.

Who are the top competitors of I-Nside?

I-Nside's top competitors include EnvantageDX, U-Smell-It and Hedera Biomedics. Among them, EnvantageDX secured the most recent funding round in January, 2021.

I-Nside - 2026 Company Profile, Team & Competitors

Company Details

I-Nside provides smartphone based, point-of-care endoscopic device. The company aims to increase the access to diagnostics in remote areas. Smart Scope, the company's endoscopic device is connected to a smartphone for imaging which makes mobile and can be carried from place to place. The company also has a computer assisted diagnosis system that automates the diagnosis of medical images of the eardrums and captures an image of an eardrum to get an immediate insight into the diagnostic.

Website: i-nside.com
Social
Email ID: *****@i-nside.com
Phone Number: +33 **********

Key Metrics

Founded Year

2015

Location

Strasbourg, France

Stage

Unfunded

Ranked

4^th among 4 active competitors

Similar Companies

EnvantageDX & 4 more

View I-Nside's full profile

I-Nside has not raised any funding rounds yet.

The founders of I-Nside is Laurent Schmoll.

Here are the details of I-Nside's key team members:

Laurent Schmoll: Founder of I-Nside.
Contact Info: 1 email address

View details of I-Nside's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of I-Nside include EnvantageDX, U-Smell-It and Hedera Biomedics. Here is the list of Top 10 competitors of I-Nside, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	EnvantageDX 2013, Austin (United States), Series A	In-vitro diagnostics for rapid ear, nose, and throat illness detection	$7.43M	Denniston Family Office, Sea Purity Investments ... & 5 others	37/100
2nd	U-Smell-It 2020, Guilford (United States), Unfunded	Provider of olfactory test to detect changes in the sense of smell	-	-	30/100
3rd	Hedera Biomedics 2014, Italy, Unfunded	Provider of various devices for diagnostic, clinical practice and clinical research	-	-	26/100
4th	I-Nside 2015, Strasbourg (France), Unfunded	Provider of smartphone based, point-of-care endoscopic device	-	-	24/100
5th	HMD 2016, Hong Kong (China), Deadpooled	All in one medical diagnostic equipment for ENT applications	-	-	16/100
6th	PATH MEDICAL 2007, Nairobi (Kenya), Deadpooled	Diagnostic devices for hearing impairment at an early stage	-	-	15/100